IPO Allotment of Om Megashree Pharmaceuticals To Be Concluded on Tuesday; Lucky 1,47,600 Applicants Will Get 10 Units Each

The IPO allotment of Om Megashree Pharmaceuticals Limited will take place this Tuesday, i.e., on 12th Chaitra, 2081. The allotment program will be held at the premises of the issue manager Prabhu Capital Limited, Lazimpat.

The company's issued capital was Rs. 60 Crores, of which 30%, i.e., 18,00,000 unit shares worth Rs. 18 Crores, had been issued later for the general public. Of this public issue, 10% of the shares, totaling 1,80,000 units, had already been issued for Nepalese citizens working abroad. Out of 18,00,000 units, 90,000 (i.e., 5% of 18,00,000) had been set aside for mutual funds, and 54,000 (i.e., 3% of 18,00,000) units had been set aside for the company's employees. The remaining 14,76,000 units were issued to the general public at a par value of Rs. 100.

According to CDSC, 19,88,836 applicants have applied for 2,36,91,510 units worth Rs. 2.36 Arba of the closing day.

Looking at the data, it is apparent that only 1,47,600 lucky applicants will get ownership of the company.

CARE Ratings Nepal Limited (CRNL) has reaffirmed the ‘CARE-NP BB- (Is)’ rating for Om Megashree Pharmaceuticals Limited (OMPL), indicating a moderate default risk for timely financial obligations. Additionally, CRNL has reaffirmed the ‘CARE-NP BB-’ rating for OMPL’s long-term bank facilities and the ‘CARE-NP A4’ rating for its short-term bank facilities.

Om Megashree Pharmaceuticals Limited, established on June 12, 2016, is a public limited company in Nepal promoted by a group of institutional and individual investors. The company manufactures pharmaceutical products at its Chitwan-based plant and began partial operations on February 19, 2024.